Autism Spectrum Disorder Trial, Recruiting NCT06329245 Sponsor: Children's Hospital of Fudan University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06329245
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have an older sibling formally diagnosed with autism spectrum disorder (ASD), where that diagnosis was confirmed using one of two standard assessment tools (ADOS-2 or ADI-R).
  • People who have an older sibling without ASD and no family history of ASD in any close or extended family member (parents, siblings, grandparents, aunts, uncles, or cousins).

Who may not be able to join:

  • People who have a diagnosis or strong physical signs of a genetic condition or syndrome (for example, fragile X syndrome) that is known to be linked to ASD.
  • People who have a significant medical or neurological condition that affects growth, development, or thinking ability (for example, a brain infection, seizure disorder, or a heart condition present from birth).
  • People who have a sensory impairment such as vision or hearing loss.
  • People who were born with a low birth weight (under 2,000 grams) or were born prematurely (before 37 weeks of pregnancy).
  • People who may have been exposed before birth to substances known to potentially harm brain development, such as alcohol or certain prescription medications.
  • People for whom an MRI scan would not be safe, for example due to metal implants in the body.
  • People who have a close family member (parent or sibling) with a history of intellectual disability, psychosis, schizophrenia, or bipolar disorder.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiu Xu, doctor, Children's Hospital of Fudan University

Phone: 13701989113

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital of Fudan University
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 January 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

clinical diagnosis; neurodevelopmental outcome; Prosocial behaviors; nuclear magnetic resonance imaging(MRI); Event related potentials (ERPs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov